QIAGEN at AMP Global 2017

The inaugural AMP Global Congress on Molecular Pathology, hosted by the Association for Medical Pathologists (AMP), is the event of the year for molecular pathology, diagnostic technologies and research and clinical applications. AMP Global 2017 is the perfect event for QIAGEN to remind and educate the market about our broad menu of Sample to Insight solutions, from trusted molecular detection to clinical decision support, which are key to success in molecular pathology.

QIAGEN is a leader in innovative solutions for molecular testing

QIAGEN has a broad menu of oncology solutions for molecular diagnostics

AMP Global 2017 will be held April 3–5, 2017 at the Estrel – Congress and Exhibition Center in Berlin, Germany, and we would love to see you there! Here are some ways you can connect with us at the event:

Find more information about all QIAGEN Sample to Insight solutions by visiting our website, and be sure to follow our live twitter feed from AMP Global 2017!

Check out QIAGEN’s stream of video footage from AMP Global 2017!

QIAGEN at AMP Global 2017 – Teaser

On the Road to AMP Global 2017

Challenges of Tumor Heterogeneity

Quality Assurance in NGS

Challenges of Liquid Biopsies

GeneReader NGS System Experience

AMP Global 2017 Posters

Importance of Standardized Workflows and Quality Control

Advances and Challenges in Cancer Research

Showcase on Detecting Cancer Mutations in Liquid Biopsy Samples

Showcase on Application of the GeneReader NGS System

AMP Global 2017 Wrap-Up

 

* Available for in vitro diagnostic (IVD) use in Europe.

** For research use only. Not for use in diagnostic procedures.

Trademarks & Disclaimers

Kathryn Collinet

Kathryn Collinet, PhD, is a Technical and Marketing Writer for Personalized Healthcare and Oncology at QIAGEN. She trained as a molecular biologist at the University of Barcelona and the Institute for Research in Biomedicine, where she studied DNA and protein modifications and their influence on chromatin conformation and gene expression. Since 2011 Kathryn has been working in marketing communications for the scientific information and molecular diagnostics industries. Kathryn has a passion for delivering knowledge and insights about molecular and clinical technologies, and their power to impact research and healthcare.

Your email address will not be published. Required fields are marked *